Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the Literature

• Ngā kaituhi matua: Guillaume Drevin (Author), Maria Pena-Martin (Author), Aurélien Bauduin (Author), Antoine Baudriller (Author), Marie Briet (Author), Chadi Abbara (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2024-08-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

3,4-Methylenedioxymethamphetamine (MDMA) is a synthetic amphetamine derivative with notable psychoactive properties and emerging therapeutic potential, particularly for treating post-traumatic stress disorders (PTSD) and substance use disorders. However, its use remains controversial due to inter-in...